Get started
Author

Yolanda Fernández

Observed names: Y Fernández, Y. Fernández, Yolanda Fernandez, Yolanda Fernández
Observed institutions: Memorial Sloan Kettering Cancer Center, Consejo Superior de Investigaciones Científicas, Harvard University, University of Michigan, Instituto de Salud Carlos III, Institut d'Investigació Biomédica de Bellvitge, Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Centro Nacional de Biotecnología, Centro de Investigación Biomédica en Red, Hospital Universitario Central de Asturias, Merck, S.L.U. (Spain), Duran i Reynals Hospital, U-M Rogel Cancer Center, Parc Científic de Barcelona, Icahn School of Medicine at Mount Sinai
ORCID: 0000-0002-2256-163X
Observed ORCID: 0000-0002-2256-163X
OpenAlex ID: A5108222638
Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications
2005 · Yolanda Fernández, Monique Verhaegen, et al. · Cancer Research · 220
Tumor cell-selective regulation of NOXA by c-MYC in response to proteasome inhibition
2007 · Mikhail A. Nikiforov, MaryBeth Riblett, et al. · Proceedings of the National Academy of Sciences · 174
KLF6-SV1 overexpression accelerates human and mouse prostate cancer progression and metastasis
2008 · Goutham Narla, Analisa DiFeo, et al. · Journal of Clinical Investigation · 110
PDF
The Host-Dependent Interaction of α-Importins with Influenza PB2 Polymerase Subunit Is Required for Virus RNA Replication
2008 · Patricia Resa-Infante, Núria Jorba, et al. · PLoS ONE · 103
PDF
Therapeutic window for melanoma treatment provided by selective effects of the proteasome on Bcl-2 proteins
2007 · K G Wolter, M Verhaegen, et al. · Cell Death and Differentiation · 73
Bcl-xL promotes metastasis of breast cancer cells by induction of cytokines resistance
2000 · Y Fernández, L España, et al. · Cell Death and Differentiation · 70
Inhibition of apoptosis in human breast cancer cells: Role in tumor progression to the metastatic state
2002 · Yolanda Fernández, Bin Gu, et al. · International Journal of Cancer · 65
PDF
Overexpression of Bcl-xL in Human Breast Cancer Cells Enhances Organ-Selective Lymph Node Metastasis
2004 · Laura España, Yolanda Fernández, et al. · Breast Cancer Research and Treatment · 60
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)
2013 · Pilar Blay, Iñigo Santamaría, et al. · BMC Cancer · 55
PDF
Chemical Blockage of the Proteasome Inhibitory Function of Bortezomib
2005 · Yolanda Fernández, Thomas P. Miller, et al. · Journal of Biological Chemistry · 46
KLF6 allelic loss is associated with tumor recurrence and markedly decreased survival in head and neck squamous cell carcinoma
2007 · Miriam S. Teixeira, Olga Camacho‐Vanegas, et al. · International Journal of Cancer · 37
PDF
Development of an HTS Assay for the Search of Anti-influenza Agents Targeting the Interaction of Viral RNA with the NS1 Protein
2008 · Marta Maroto, Yolanda Fernandez, et al. · SLAS DISCOVERY · 28
PDF
Chemical Genomics Identifies the PERK-Mediated Unfolded Protein Stress Response as a Cellular Target for Influenza Virus Inhibition
2016 · Sara Landeras-Bueno, Yolanda Fernández, et al. · mBio · 24
PDF
Evaluation of international treatment guidelines and prognostic tests for the treatment of early breast cancer
2008 · Montserrat Muñoz, Laura G. Estévez, et al. · Cancer Treatment Reviews · 23
Anti-apoptotic Proteins Induce Non-random Genetic Alterations that Result in Selecting Breast Cancer Metastatic Cells
2005 · Olga Méndez, Yolanda Fernández, et al. · Clinical & Experimental Metastasis · 17
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanes
2003 · Rosa Sánchez, Emilio Esteban, et al. · Investigational New Drugs · 13
Development and validation of a sexual relations satisfaction scale in patients with breast cancer — “SEXSAT-Q”
2019 · Rosario González Mancha, Montserrat Muñoz, et al. · Health and Quality of Life Outcomes · 12
PDF
Breast cancer management in the elderly
2013 · M. Luque, F. Arranz, et al. · Clinical & Translational Oncology · 7
Finding the right dose of fulvestrant in breast cancer
2012 · L. Estévez, I. Alvarez, et al. · Cancer Treatment Reviews · 6
Current controversies in the management of breast cancer
2010 · Ignasi Tusquets, Laura García-Estévez, et al. · Clinical & Translational Oncology · 3
Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias ( North Spain )
2024 · Ana S. Pitiot, Pilar Blay, et al. · Clinical Genetics
Author response for "Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias ( North Spain )"
2024 · Ana S. Pitiot, Pilar Blay, et al. · Publons reviews and discussion
Author response for "Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias ( North Spain )"
2024 · Ana S. Pitiot, Pilar Blay, et al. · Publons reviews and discussion
Supplementary Figures 1-6 from Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications
2023 · Yolanda Fernández, Monique Verhaegen, et al.
PDF
Supplementary Information from Differential Regulation of Noxa in Normal Melanocytes and Melanoma Cells by Proteasome Inhibition: Therapeutic Implications
2023 · Yolanda Fernández, Monique Verhaegen, et al.
Works count: 33
Citation count: 1,146
H-index: 15
I10-index: 17
Year
Topic
Type